Fig. 3.

Baseline-adjusted 24-h, daytime, night-time, last 6-h and morning surge SBP mean changes (and 95% confidence interval) after 12 weeks of double-blind treatment with olmesartan 10–40 mg (open bars) and ramipril 2.5–10 mg (grey bars). Data are shown for the whole population (n = 715) and for sustained hypertensive patients (n = 582). Asterisks refer to the statistical significance of between-treatment differences (**p < 0.001; *p < 0.05).

Redrawn from Omboni S, Malacco E, Mallion JM, Volpe M, Zanchetti A, Study Group. Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies. J Hypertens. 2012;30(7):1468–77. https://journals.lww.com/jhypertension/Abstract/2012/07000/Twenty_four_hour_and_early_morning_blood_pressure.28.aspx